The U.S. Food and Drug Administration (FDA) has issued a final guidance on “Civil Money Penalties Relating to the ClinicalTrials.gov Data Bank” outlining the agency’s current thinking regarding penalties imposed […]
All of those lofty goals and high aspirations associated with the term “patient centricity” won’t meet their potential unless all stakeholders come together to swap ideas, confront challenges, and share […]
The U.S. Food and Drug Administration (FDA) has created a special emergency program for possible coronavirus therapies, the Coronavirus Treatment Acceleration Program (CTAP). The program uses every available method […]
Clinical Researcher—August 2020 (Volume 34, Issue 7) PEER REVIEWED Yaritza Peña; Zachary P. Smith; Kenneth A. Getz, MBA It is well known that the underrepresentation of minority groups in […]
Clinical Researcher—August 2020 (Volume 34, Issue 7) PEER REVIEWED Mario Esquivel, MS, ACRP-CP Tobacco use in the United States amongst adults has consistently been the leading cause of preventable […]